LianBio reports results for the quarter ended in June - Earnings Summary

LianBio

14/08/2023 22:52

* LianBio  LIAN.OQ  reported a quarterly adjusted loss of 20
cents​​ per share for the quarter ended in June. The mean
expectation of four analysts for the quarter was for a loss
of 28 cents per share.
    * Reported revenue was zero​; analysts expected zero. 
    * LianBio's reported EPS for the quarter was a loss of 20
cents​.
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company. 
    * LianBio shares had fallen by 18.9% this quarter and
gained 12.8%
so far this year.
    * The company reported a quarterly loss of $21.62 million.
    * Wall Street's median 12-month price target for LianBio is
$6.50 
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 3 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell." 

This summary was machine generated from LSEG Refinitiv data
August 14 at 09:52 p.m. UTC. ​All figures in US dollars unless
otherwise stated. QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Jun. 30 2023      -0.28          -0.20          Beat
 Mar. 31 2023      -0.27          -0.22          Beat
 Dec. 31 2022      -0.27          -0.17          Beat
 Sep. 30 2022      -0.39          -0.20          Beat